This is the second part of a three-part blog post on the difference between biologics vs. small molecules for stability testing. This post’s focus is on analytical testing which for biologics is significantly different than small molecules.    

There are similarities for stability testing of biologics vs. small molecules, but there are also significant differences. In this first of a three-part blog post, I’ll breakdown what is faced in stability testing of these two product types and how each are handled. The second post will focus on the difference in analytical testing and the final post will be on degradation. Hopefully you find this useful!